Works matching Castration

Results: 5000
    1
    2
    3
    4
    5

    Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data.

    Published in:
    Current Medical Research & Opinion, 2021, v. 37, n. 4, p. 609, doi. 10.1080/03007995.2021.1879753
    By:
    • Freedland, Stephen J.;
    • Ke, Xuehua;
    • Lafeuille, Marie-Hélène;
    • Romdhani, Hela;
    • Kinkead, Frederic;
    • Lefebvre, Patrick;
    • Petrilla, Allison;
    • Pulungan, Zul;
    • Kim, Seung;
    • D'Andrea, Denise M.;
    • Francis, Peter;
    • Ryan, Charles J.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2020, v. 25, n. 3, p. 479, doi. 10.1007/s10147-019-01541-8
    By:
    • Mori, Keiichiro;
    • Kimura, Takahiro;
    • Fukuokaya, Wataru;
    • Iwatani, Kosuke;
    • Sakanaka, Keigo;
    • Kurokawa, Gaku;
    • Yanagisawa, Takafumi;
    • Sasaki, Hiroshi;
    • Miki, Jun;
    • Shimomura, Tatsuya;
    • Miki, Kenta;
    • Hatano, Takashi;
    • Endo, Katsuhisa;
    • Egawa, Shin
    Publication type:
    Article
    14
    15
    16

    Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study.

    Published in:
    World Journal of Urology, 2022, v. 40, n. 10, p. 2459, doi. 10.1007/s00345-022-04108-x
    By:
    • Angulo, J. C.;
    • Ciria Santos, J. P.;
    • Gómez-Caamaño, A.;
    • Poza de Celis, R.;
    • González Sala, J. L.;
    • García Garzón, J. M.;
    • Galán-Llopis, J. A.;
    • Pérez Sampietro, M.;
    • Perrot, V.;
    • Planas Morin, J.;
    • on behalf of ANARESISTANCE study group;
    • Abascal, José Manuel;
    • Barrond, Víctor;
    • Benedicto, Antonio;
    • Carballo, Ana;
    • Cortiñas, José Ramón;
    • Fernández, Manuel;
    • Ferrer, Eduardo;
    • Guzmán, Pablo Luís;
    • López, Miguel Ángel
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.

    Published in:
    BMC Urology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12894-022-01096-3
    By:
    • Sugimoto, Mikio;
    • Kato, Takuma;
    • Tohi, Yoichiro;
    • Shimizu, Yosuke;
    • Matsumoto, Ryuji;
    • Inoue, Takahiro;
    • Takezawa, Yutaka;
    • Masui, Kimihiko;
    • Sasaki, Hiroshi;
    • Hirama, Hiromi;
    • Saito, Shiro;
    • Egawa, Shin;
    • Kamoto, Toshiyuki;
    • Teramukai, Satoshi;
    • Kojima, Shinsuke;
    • Kikuchi, Takashi;
    • Kakehi, Yoshiyuki
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 427, doi. 10.1007/s10147-022-02288-5
    By:
    • Oka, Toshiki;
    • Hatano, Koji;
    • Okuda, Yohei;
    • Yamamoto, Akinaru;
    • Uemura, Toshihiro;
    • Yamamichi, Gaku;
    • Tomiyama, Eisuke;
    • Ishizuya, Yu;
    • Yamamoto, Yoshiyuki;
    • Kato, Taigo;
    • Kawashima, Atsunari;
    • Fujita, Kazutoshi;
    • Nonomura, Norio
    Publication type:
    Article
    48
    49
    50